Inventor · disambiguated record
Klaus Edvardsen
Also filed as: DORSEY JAMES M · EDVARDSEN KLAUS
11 granted patents·4 pending applications·56 citations·filing 2001–2014
88Inventor score
Top patents by PatentIndex Score
15 records- 0185US6919324B2Functionalized stilbene derivatives as improved vascular targeting agentsUNIV BAYLOR·Filed 2002·Granted Jul 19, 2005·19 cites·12 claims
- 0283US7384925B2Functionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2005·Granted Jun 10, 2008·6 cites·8 claims
- 0379US7001926B2Tubulin binding agents and corresponding prodrug constructsUNIV BAYLOR·Filed 2003·Granted Feb 21, 2006·10 cites·28 claims
- 0473US7456214B2Chromene-containing compounds with anti-tubulin and vascular targeting activityUNIV BAYLOR·Filed 2004·Granted Nov 25, 2008·7 cites·20 claims
- 0573US6773702B2Use of combretastatin A4 and its prodrugs as an immune enhancing therapyOXIGENE INC·Filed 2001·Granted Aug 10, 2004·5 cites·13 claims
- 0671US9428582B2Method of treating rash in patients undergoing anti-EGFR therapyEDVARDSEN KLAUS·Filed 2007·Granted Aug 30, 2016·3 cites·34 claims
- 0769US7091240B2Tubulin binding ligands and corresponding prodrug constructsUNIV BAYLOR·Filed 2003·Granted Aug 15, 2006·3 cites·28 claims
- 0867US2009258937A1Methods for Modulating Tumor Growth and MetastasisLEE FRANCIS Y·Filed 2008·Application pending·0 cites
- 0965US8198302B2Compositions and methods with enhanced therapeutic activityCHAPLIN DAVID J·Filed 2004·Granted Jun 12, 2012·3 cites·8 claims
- 1061USRE45720EFunctionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2014·Granted Oct 6, 2015·0 cites·12 claims
- 1159USRE45907EFunctionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2014·Granted Mar 1, 2016·0 cites·8 claims
- 1250US2005209310A1Methods for modulating tumor growth and metastasisCHAPLIN DAVID J·Filed 2004·Application pending·0 cites
- 1349US9540450B2Methods and antibodies for treating cancerGENMAB AS·Filed 2014·Granted Jan 10, 2017·0 cites·14 claims
- 1448US2011256142A1Novel methods and antibodies for treating cancerGENMAB AS·Filed 2008·Application pending·0 cites
- 1533US2005245489A1Chromene-containing compounds with anti-tubulin and vascular targeting activityPINNEY KEVIN G·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus Edvardsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →